Skip to main content

Lacy R. Moss, PhD, MLS(ASCP)CM

Languages spoken: English

Academic Information

Departments: Pathology - Assistant Professor (Lecturer)

Divisions: Medical Laboratory Science

Academic Office Information

lacy.moss@path.utah.edu

(801) 587-1733

Utah Department of Health
Medical Laboratory Science Division
44 N Mario Capecchi Drive, Room: 240.10
Salt Lake City, UT 84114

Board Certification

  • American Society for Clinical Pathology (Medical Laboratory Scientist)

My teaching expertise is in the field of Medical Laboratory Science in particular in Clinical Chemistry, Urinalysis and Body Fluid Analysis, Basic Laboratory Techniques, and Education and Research. I am interested in helping students learn in a way that works for them by providing multiple learning formats such as images, summary tables, audio recordings, and video demonstrations. In my courses, I try to highlight concepts and relate information to the students in a way that is personal and easy to remember. In my laboratory courses, I gear the didactic exercises to mimic actual practice in order to foster teamwork, professionalism, application of lecture material, and troubleshooting skills.

Education History

Doctoral Training University of Texas Southwestern Medical Center
Cancer Biology and Mechanism of Disease track
Ph.D.
Undergraduate University of North Carolina at Chapel Hill
Clinical Laboratory Science; Minor in Chemistry
B.S.

Selected Publications

  1. Moss LR, Mulik RS, Van Treuren T, Kim SY, Corbin IR (2016). Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells. Biochim Biophys Acta, 1860(11 Pt A), 2363-2376.
  2. Satapati S, Kucejova B, Duarte JA, Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu X, Merritt ME, Sherry AD, Malloy CR, Shelton JM, Lambert J, Parks EJ, Corbin I, Magnuson MA, Browning JD, Burgess SC (2016). Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest (126(4), p. 1605). United States.
  3. Wen X, Reynolds L, Mulik RS, Kim SY, Van Treuren T, Nguyen LH, Zhu H, Corbin IR (2015). Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats. Gastroenterology, 150(2), 488-98.
  4. Satapati S, Kucejova B, Duarte JA, Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu X, Merritt ME, Sherry AD, Malloy CR, Shelton JM, Lambert J, Parks EJ, Corbin I, Magnuson MA, Browning JD, Burgess SC (2015). Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest, 125(12), 4447-62.
  5. Reynolds L, Mulik RS, Wen X, Dilip A, Corbin IR (2014). Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells. Nanomedicine (Lond), 9(14), 2123-41.